Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies. Our products and services are used to help care for critically and chronically ill patients.
Our product portfolio comprises a comprehensive range of IV generic drugs, infusion therapies and clinical nutrition products, as well as medical devices for administering these products. Within transfusion technologies, we offer products for the collection and processing of blood components and for the therapeutic treatment of blood by apheresis systems. In the field of biosimilars, we develop products with a focus on oncology and autoimmune diseases.
Fresenius Kabi has a heritage of devotion towards providing high-quality and affordable products while upholding our tradition of putting patients first, which we are now carrying forward into our emergent biosimilars offering.
Fresenius Kabi is a company of the Fresenius Group, a global healthcare group which was founded in 1912 and offers high-quality products and services for dialysis, hospitals and outpatient treatment.
FK/BIO/021/18 | February 2019